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ABSTRACT
Cannabis use is highly prevalent and often considered to be relatively harmless. Nonetheless, a subset of regular
cannabis users may develop dependence, experiencing poorer quality of life and greater mental health problems
relative to non-dependent users. The neuroanatomy characterizing cannabis use versus dependence is poorly
understood. We aimed to delineate the contributing role of cannabis use and dependence on morphology of the
hippocampus, one of the most consistently altered brain regions in cannabis users, in a large multi-site dataset
aggregated across four research sites. We compared hippocampal volume and vertex-level hippocampal shape
differences (1) between 121 non-using controls and 140 cannabis users; (2) between 106 controls, 50 non-
dependent users and 70 dependent users; and (3) between a subset of 41 controls, 41 non-dependent users and 41
dependent users, matched on sample characteristics and cannabis use pattern (onset age and dosage). Cannabis users
did not differ from controls in hippocampal volume or shape. However, cannabis-dependent users had significantly
smaller right and left hippocampi relative to controls and non-dependent users, irrespective of cannabis dosage.
Shape analysis indicated localized deflations in the superior-medial body of the hippocampus. Our findings support
neuroscientific theories postulating dependence-specific neuroadaptations in cannabis users. Future efforts should
uncover the neurobiological risk and liabilities separating dependent and non-dependent use of cannabis.
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INTRODUCTION
Cannabis use has been widespread globally over the past
two decades, with the most recent census estimating a
prevalence of up to 183 million users (United Nations
Office on Drugs and Crime 2016). This number may
increase with recent legislative changes and more liberal
policies surrounding both recreational and medicinal
cannabis use, fueling debate on public health conse-
quences, such as the potential increase in cannabis
dependence and cannabis-related problems (Hasin et al.
2017). Despite a general community perception of
harmlessness, a subset of regular cannabis users—over
13 million—are dependent on cannabis (Degenhardt
et al. 2013; United Nations Office on Drugs and Crime
2016). In addition, almost 50 percent of substance users
seeking treatment are cannabis dependent (United
Nations Office on Drugs and Crime 2016). Cannabis
dependence represents a significant burden on the indi-
vidual and society but has been poorly defined
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neurobiologically compared with heavy, non-dependent
use. This warrants greater attention to distinctions be-
tween cannabis use and dependence and associated
harms and vulnerabilities.
Individuals with cannabis dependence report dimin-
ished control over use and compulsive use despite asso-
ciated negative consequences to their functioning and
mental health (American Psychiatric Association
2013; van der Pol et al. 2013a). Relative to non-
dependent users, they also experience greater mental
health issues (i.e. mood, anxiety and conduct disorder)
(van der Pol et al. 2013a) and impaired cognitive func-
tioning in the domains of learning, working memory
and cognitive flexibility (Solowij & Battisti 2008; Broyd
et al. 2016). Such impaired functioning may be
underpinned by neuroanatomical alterations across
brain regions relevant to motivation, emotion and cog-
nition (Koob 2009; Chambers 2013), as demonstrated
in regular cannabis users with higher levels of use
and problem use (Koenders et al. 2016; Lorenzetti,
Solowij, & Yücel 2016c). In particular, the hippocam-
pus is often suggested to be affected by cannabis users,
with a number of studies reporting hippocampal vol-
ume to be reduced in regular cannabis users relative
to non-users (Yücel et al. 2008; Ashtari et al. 2011;
Demirakca et al. 2011; Rocchetti et al. 2013; Koenders
et al. 2016; Yücel et al. 2016). However, almost as
many studies have not observed cannabis-use-related
hippocampal alterations (Tzilos et al. 2005; Medina
et al. 2007; Gilman et al. 2014; Mashhoon et al.
2015; Weiland et al. 2015). The wide-ranging sample
characteristics across studies (e.g. average duration of
use range from 3 to 20 years; average age of user sam-
ple range from 20 to 40 years old), the small sample
size of individual studies (i.e. range of cannabis-using
sample from 11 to 61) and the lack of consideration
of cannabis dependence preclude identification of key
factors involved in specific hippocampal aberrations.
Emerging evidence demonstrates differences between
non-dependent and dependent cannabis users in brain
structure [i.e. orbitofrontal cortex and hippocampal vol-
ume (Chye et al. 2017a; Chye et al. 2017b)] and brain
function [i.e. functional connectivity across amygdala,
anterior cingulate, orbitofrontal cortex, hippocampus
and nucleus accumbens (Filbey & Dunlop 2014)]. Such
findings may reflect neural adaptations that discriminate
compulsive use in substance dependence (Koob 2009;
Chambers 2013; Koob & Volkow 2017). However, most
previous studies of regular cannabis users have not
clarified the differences specific to dependence versus
non-dependence in regular cannabis users. It is impor-
tant to distinguish between these groups to improve
identification and prevention in user populations most
vulnerable to cannabis-related harms.
We aimed to delineate the contributing roles of can-
nabis use and dependence on the hippocampus, one of
the most consistently reported brain regions to be
altered in cannabis users (Lorenzetti et al. 2016c), by
re-examining hippocampal morphology across an ag-
gregated sample of 261 cannabis users (dependent
and non-dependent) and non-using controls (CON)
from four research sites globally (Batalla et al. 2013;
Solowij et al. 2013; Cousijn et al. 2014; Yücel et al.
2016). While the aforementioned study findings have
been mixed in relation to hippocampal morphology in
diverse cannabis using samples, none of these studies
specifically examined cannabis dependence relative to
non-dependent heavy use. We compared hippocampal
morphology (i.e. both volume and shape) between (1)
regular cannabis users (CB) and non-using CON and
between (2) dependent users (CB-dep), non-dependent
users (CB-nondep) and CON. To validate potential
dependence-related hippocampal morphological differ-
ences, we further examined hippocampal volume and
shape between (3) a subset of CB-dep, CB-nondep and
CON, matched on age, gender distribution, intelligence
quotient (IQ) and alcohol use, with CB-dep and CB-
nondep further matched on tobacco use and cannabis
use (i.e. onset and dosage). We hypothesized that
hippocampal volume reduction and shape alteration
would be apparent in regular cannabis users (both
CB-dep and CB-nondep) relative to CON and that these




Participants comprising 121 CON (aged 18 to 55;
Mdn = 24 years) and 140 CB (aged 18 to 56;
Mdn = 24 years) were recruited from four indepen-
dently conducted studies across Amsterdam (N = 76;
Cousijn et al. 2014), Barcelona (N = 55; Batalla et al.
2013), Wollongong (N = 30; Solowij et al. 2013) and
Melbourne (N = 100; Yücel et al. 2016). Inclusion
and exclusion criteria have been documented in a pre-
vious paper (Chye et al. 2017a) and in the Supplemen-
tary Table S1. Briefly, CB had to have used cannabis at
least 2 days/month for at least 2 months, although
most CB had almost daily cannabis use for a consider-
able period of time (duration of regular use,
Mdn = 6 years, range = 0.5–38 years; lifetime use,
Mdn = 15 690 cones, range = 600–864 000 cones).
Meanwhile, CON used less than 50 times in their life-
time and did not use in the past month. All subjects
had no history of chronic medical illness or neurologi-
cal conditions or any lifetime Axis I psychiatric disorder
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apart from nicotine use disorder or cannabis use disor-
der and had minimal illicit substance use other than
cannabis (<50 times in the past 10 years).
Measures
Participants’ demographic and substance use character-
istics were assessed separately at each individual research
site. Select information [i.e. age, gender, IQ, monthly
tobacco (cigarettes) use, monthly standard alcoholic
drinks and cannabis use measures] was subsequently
standardized across sites (refer measures in Supplemen-
tary Table S1). Cannabis use measures included monthly
and lifetime cannabis consumption (measured in cones,
https://cannabissupport.com.au/media/1593/timeline-
followback.pdf), age of initiation of regular cannabis use
and cannabis dependence.
Cannabis dependence information was only available
from three of the four sites and was used to separate
the aggregated three-site sample into 70 CB-dep, 50 CB-
nondep and 106 CON based on recommended norms
and after excluding subjects with missing dependence
information. Specifically, in Amsterdam, the Mini
International Neuropsychiatric Interview’s ‘non-alcohol
psychoactive substance use disorders’ module was used,
with a cut-off of 3 and above as CB-dep (Lecrubier et al.
1997), while Barcelona and Melbourne used the Severity
of Dependence Scale, with a cut-off of 4 and above as
CB-dep (Gossop et al. 1995).
Structural image processing
T1-weighted structural magnetic resonance images were
acquired separately from each research site. Scanner de-
tails have been documented previously (Batalla et al.
2013; Solowij et al. 2013; Cousijn et al. 2014; Yücel
et al. 2016; Chye et al. 2017a), as well as in Supplemen-
tary Table S1. Two sites used a Phillips Intera 3T
scanner with an 8-channel head coil (Amsterdam and
Wollongong), one site used a GE Signa Excite 1.5T scan-
ner with an 8-channel head coil (Barcelona) and one site
used a Siemens-Trio 3T scanner with a 32-channel head
coil (Melbourne).
Magnetic resonance images were corrected for
intensity inhomogeneity—nonparametric nonuniform
intensity normalization (Sled, Zijdenbos, & Evans 1998)
using FreeSurfer image analysis (http://surfer.nmr.mgh.
harvard.edu/) version 5.3.0. An estimate of the intracra-
nial volume (ICV) was also obtained from FreeSurfer’s
automated parcellation procedure. Subsequently, the im-
ages’ intensity was standardized across sites, based on the
average gray matter, white matter and cerebrospinal fluid
intensity from each site, using the FMRIB Software
Library (FSL; http://www.fmrib.ox.ac.uk/fsl/). Finally,
the images were visually inspected to ensure consistent
orientation along the anterior commissure–posterior
commissure plane.
Volumetric analysis
The hippocampus was manually traced by a trained
tracer (Y. C.) blinded to group and site membership, using
the Analyze 12.0 software (AnalyzeDirect, Overland
Park, KS), according to a validated protocol (Velakoulis
et al. 1999). Hippocampal boundaries were defined poste-
riorly as the slice with the greatest length of continuous
fornix; medially as the open end of the hippocampal
fissure (posterior) and the uncal fissure (anterior); later-
ally as the temporal horn of the lateral ventricle;
inferiorly as the parahippocampal white matter; and
superiorly as the fimbria and alveus (posterior) as well
as the amygdala (anterior).
Intra-rater and inter-rater reliabilities (i.e. intraclass
correlation coefficient, absolute agreement and single
measures) for the hippocampal tracing were assessed on
28 randomly selected images. Intra-rater reliabilities for
the right and left hippocampus were 0.97 and 0.88,
respectively, while inter-rater reliabilities against an
expert tracer (V. L.) were 0.90 and 0.93, respectively.
Intra-rater reliability was also consistent across scanner
field strength, at an intraclass correlation coefficient of
0.95 (collapsed across both hemispheres) for both 1.5T
and 3T scanners. As tracing of all 261 images proceeded
over a 4-month period (from April to August 2016),
longitudinal intra-rater reliability was performed on 15
images (i.e. five images repeated 3 times, evenly distrib-
uted across the blinded sample). Values were 0.93 and
0.83 for the right and left hippocampus, respectively,
indicating good consistency over time.
A series of univariate analysis of covariance models
were run to examine the association between cannabis
use and dependence and left and right hippocampus
volume. This included (1) comparison between CON
and CB, controlling for imaging site as random factor,
gender as fixed factor, and ICV, age, IQ and monthly
alcohol and tobacco use as covariates; (2a) comparison
between CON, CB-nondep and CB-dep (only from the
three sites that obtained dependence measures—
Amsterdam, Barcelona and Melbourne), controlling for
all previously mentioned variables; (2b) comparison
between CB-nondep and CB-dep users only, with addi-
tional inclusion of all cannabis use measures (current
monthly cones, lifetime cones and age of regular use) as
covariates; and (3) comparison between CON, CB-nondep
and CB-dep, in a subset of subjects matched on gender,
age, IQ and alcohol use across all groups and matched
on tobacco and cannabis use (current monthly cones,
824 Yann Chye et al.
© 2018 Society for the Study of Addiction Addiction Biology, 24, 822–834
lifetime cones and age of regular use) across CB-nondep
and CB-dep.
Shape analysis
The manually traced hippocampal boundaries (i.e. object
maps) were used to run shape analysis within FSL. First,
the object maps were registered to Montreal Neurological
Institute space, with reference from their respective T1-
weighted images. Next, average boundary images for
the hippocampal object maps (separately for the right
and left hippocampus) were obtained. To do this, we first
averaged the object maps together and binarized them at
the 60 percent threshold. From this, we formed a 1-voxel-
thick average boundary shape by subtracting away an
eroded version of the threshold-shape. The signed dis-
tance of each individual hippocampal object to every
point on the average boundary shape could then be cal-
culated. A flow chart of the shape analysis processing
steps is presented in Supplementary Fig. S1.
The signed distances for each hippocampal label were
used for further statistical analysis. A permutation-based
approach with threshold-free cluster enhancement was
adopted using FSL’s randomize tool (Smith & Nichols
2009; Winkler et al. 2014). A total of 100 000 permu-
tations were used for the analysis, examining shape
differences between (1) CON versus CB and (2) CON
versus CB-nondep versus CB-dep and (3) the matched
subset of CON versus CB-nondep versus CB-dep, all con-
trolling for imaging site, gender, age, IQ, alcohol use and
tobacco use.
Automated segmentation versus manual tracing
Given that it is often unfeasible for all studies, particu-
larly studies with large databases, to quantify brain
structures via manual tracing, we further compared
the performance of the automated tool—FreeSurfer in
hippocampal segmentation, by replicating all volume
and shape analysis. Hippocampal segmentation was
performed by FreeSurfer version 5.3, as described by
Fischl et al. (2002). Shape analysis was also performed
with a similar processing step as presented in Supple-
mentary Fig. S1. The automated segmentation proce-
dure was also validated against our manual tracing,
which is considered the gold standard for evaluating
hippocampal volume (Velakoulis et al. 1999), by exam-
ining the (1) correlation between both methods and the
(2) percent volume overlap (i.e. Dice coefficient, DICE)
as defined by the equation
DICE ¼ V manual ∩ Freesurferð Þ
V manualð Þ þ V freesurferð Þð Þ=2100:
RESULTS
Sample characteristics
Participant characteristics and hippocampal volume
measures (1) by cannabis use (i.e. CON versus CB) and
(2) by cannabis dependence (i.e. CON versus CB-nondep
versus CB-dep) are presented in Tables 1 and 2, respec-
tively. The separate data from each imaging site are pre-
sented in Supplementary Tables S2 and S3.
A subset of matched CON, CB-nondep and CB-dep
were selected, to verify volumetric findings. CB-nondep
and CB-dep were matched on age, gender, IQ and alcohol,
tobacco and cannabis use pattern within each site. This
was carried out by first obtaining the mean and standard
deviation of each continuous variable of the
smallest/reference group (i.e. x̅ref and σ ref, respectively)
by site. Subsequently, each subject’s distance score (D)
from the reference group, on all variables, was calculated
using the equation
D ¼ ∑ xv  xref:xð Þ=σref:xj j
where v = the variables: age, IQ, alcohol, tobacco, can-
nabis onset, cannabis monthly use and cannabis lifetime
use. Cannabis-using subjects were ranked and selected
by their distance from the reference group. Meanwhile,
control subjects were first selected for smoking status,
due to the relatively low number of tobacco users in
CON relative to CB. Subsequently, the previous equation
was applied to select for CON with the lowest distance
from the reference group, with regard to age, IQ and alco-
hol and tobacco use. Nevertheless, we were unable to
match CON to CB-nondep and CB-dep on tobacco use,
from the Melbourne site. Characteristics and hippocampal
volume measures of their matched subset is presented in
Table 3 and by imaging site in Supplementary Table S4.
Hippocampal volume comparisons by cannabis use—
manual tracing
CON and CB did not differ significantly in right or left
hippocampal volume (Table 1).1 Females had smaller
hippocampi compared with males (F1,250 = 12.02 and
20.00 for the right and left hippocampus, respectively,
P ≤ 0.001, ηp2 ≥ 0.046). A site effect was also found
(F3,250 = 12.34 and 10.65 for the right and left hippo-
campus, respectively, P< 0.001, ηp
2 ≥ 0.129), with partic-
ipants from Barcelona demonstrating smaller hippocampi
than participants from every other site (P ≤ .006), while
1 Four CON from the Amsterdam site used between 15 to 50
cannabis joints in their lifetime. When analysis was re-run ex-
cluding these subjects, the insignificant group effect remained
(F1,246 = 2.32 and 1.58, P = 0.13 and 0.21) for the right and
left hippocampus, respectively.
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Table 1 Sample characteristics and magnetic resonance volumetric measures of controls (CON) and cannabis users (CB) averaged
across four sites [mean (SD)].
CON (N = 121) CB (N = 140) t259/χ
2
Age (years) 26.12 (9.03) 28.03 (10.25) 1.58
Gender (% M/F) 70.25/29.75 67.14/32.86 0.29
IQa 109.31 (10.54) 103.45 (10.74) 4.44***
Alcohol (StDr/mth)b 19.87 (23.77) 24.43 (25.18) 1.50
Tobacco (Cig/mth)b 30.88 (97.92) 254.96 (233.77) 9.82***
Cannabis use
Age of regular use - 17.84 (3.38) -
Current use (cones/month) - 334.08 (322.32) -
Lifetime use (cones) - 57 107 (99 987) -
Volumetric measures (mm3)
Intracranial volume (106) 1.55 (0.20) 1.52 (0.17) 1.31
Right hippocampus
Manual 2584.45 (362.77) 2411.68 (316.24) 2.50d
FreeSurferc 4509.66 (469.21) 4381.56 (414.04) 0.00d
Left hippocampus
Manual 2455.05 (342.42) 2314.68 (307.18) 1.56d
FreeSurferc 4467.87 (434.48) 4334.63 (434.42) 0.04d
aEstimated intelligence quotient (IQ) measured with the Dutch version of the National Adult Reading Test (Schmand et al. 1991) (Amsterdam), the vo-
cabulary subscale of the Wechsler Adult Intelligence Scale—Third Edition (Wechsler 1997) (Barcelona); the National Adult Reading Test (Nelson 1982)
(Wollongong); and theWechsler Abbreviated Scale of Intelligence (Wechsler 1999) (Melbourne). bStDr/mth = standard drinks per month; Cig/mth = cig-
arettes smoked per month. cTwo CON subjects were excluded due to poor FreeSurfer hippocampal segmentation (i.e. outlier with hippocampal volume of
2204.48 and 2037.21, respectively), resulting in n of CON = 119. dF statistic for group comparison of hippocampal volume, controlling for imaging site
as random factor, gender as fixed factor and ICV, age, IQ and monthly alcohol and tobacco use as covariates. Refer to Supplementary Table S5 for full
results. *P < 0.05. **P < 0.01. ***P < 0.001.
Hyphen indicates that no data are available/necessary for those places – i.e. non-user controls do not have cannabis use data.
Table 2 Sample characteristics and magnetic resonance volumetric measures of controls (CON), non-dependent (CB-nondep) and
dependent (CB-dep) cannabis users averaged across three sites [mean (SD)].
CON (N = 106) CB-nondep (N = 50) CB-dep (N = 70) t223/χ
2
Age (years) 24.77 (7.91) 27.07 (10.33) 26.74 (9.18) 1.61
Gender (% M/F) 66.98/33.02 60.00/40.00 64.29/35.71 0.73
IQa 108.65 (10.71) 103.03 (11.13) 102.13 (10.86) 9.15***d
Alcohol (StDr/mth)b 18.70 (23.90) 21.54 (25.03) 21.88 (22.78) 0.46
Tobacco (Cig/mth)b 30.94 (96.72) 236.90 (249.97) 219.72 (197.66) 35.89***e
Cannabis use
Age of regular use - 17.79 (2.66) 17.44 (3.23) 0.61
Current use (cones/month) - 229.81 (202.25) 351.64 (290.95) 2.54*
Lifetime use (cones) - 32 375 (47 641) 50 431 (72 812) 1.54
Volumetric measures (mm3)
Intracranial volume (106) 1.53 (0.19) 1.46 (0.19) 1.53 (0.15) 2.72
Right hippocampus
Manual 2542.21 (323.36) 2474.32 (326.97) 2340.50 (287.51) 5.91**f
FreeSurferc 4476.59 (449.19) 4425.79 (379.48) 4374.22 (422.98) 2.04f
Left hippocampus
Manual 2420.41 (312.78) 2368.56 (329.54) 2250.19 (278.38) 4.49*f
FreeSurferc 4453.60 (418.80) 4386.12 (446.93) 4299.16 (422.87) 3.22**f
aEstimated intelligence quotient (IQ) measured with the Dutch version of the National Adult Reading Test (Schmand et al. 1991) (Amsterdam), the vo-
cabulary subscale of the Wechsler Adult Intelligence Scale—Third Edition (Wechsler 1997) (Barcelona); and the Wechsler Abbreviated Scale of Intelli-
gence (Wechsler 1999) (Melbourne). bStDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month. cTwo CON subjects were
excluded due to poor FreeSurfer hippocampal segmentation (i.e. outlier with hippocampal volume of 2204.48 and 2037.21, respectively), resulting
in n of CON = 104. dCON > CB-nondep, P = 0.003; CON > CB-dep, P < 0.001. eCON < CB-nondep, P < 0.001; CON < CB-dep, P < 0.001. fF statistic
for group comparison of hippocampal volume, controlling for imaging site as random factor, gender as fixed factor and ICV, age, IQ and monthly alcohol
and tobacco use as covariates. Refer to Supplementary Table S5 for full results. *P < 0.05. **P < 0.01. ***P < 0.001.
Hyphen indicates that no data are available/necessary for those places – i.e. non-user controls do not have cannabis use data.
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participants from Amsterdam had larger hippocampi
than participants from Melbourne (P ≤ 0.018). IQ signifi-
cantly affected left hippocampus volume (F1,250 = 4.33,
P = 0.039, ηp
2 = 0.017). None of the other covariates
(i.e. age, IQ, alcohol use and tobacco use) were statisti-
cally significant in the model (P ≥ 0.054, ηp2 ≤ 0.015).
Hippocampal volume comparisons by cannabis
dependence—manual tracing
Analyses comparing CON, CB-nondep and CB-dep (from
three sites) revealed a significant effect of dependence
group in the right (F2,215 = 5.91, P = 0.003, ηp
2 = 0.052,
medium-effect size) and left (F
2,215
= 4.49, P = 0.012,
ηp
2 = 0.040, medium-effect size) hemisphere (Table 2).2
CB-dep had significantly smaller right and left hippo-
campi compared with both CON (P = 0.003 and 0.008)
and CB-nondep (P = 0.006 and 0.016) (Fig. 1). As in
the four-site analysis, gender (F1,215 = 16.39 and 27.57
for right and left hippocampus, respectively, P < 0.001)
and site effects (F2,215 = 19.18 and 15.89 for right and
left hippocampus, respectively, P < 0.001) were
significant. Females had smaller hippocampi than males,
and again, participants from the Barcelona site had
smaller hippocampi than those from the other two sites
(P ≤ 0.001), while participants from the Amsterdam site
had larger hippocampi than those from Melbourne
(P ≤ 0.026). None of the covariates were statistically
significant in the model (P ≥ 0.087, ηp2 ≤ 0.014).
To establish the specificity of volumetric differences to
cannabis dependence rather than cannabis use or
exposure (and particularly because CB-dep had signifi-
cantly greater monthly use than CB-nondep), CB-dep
and CB-nondep were further compared, additionally
controlling for cannabis use measures (current monthly
cones, lifetime cones and age of regular use). The signifi-
cant group difference persisted, with CB-dep showing
smaller right (F1,104 = 6.02, P = 0.016, ηp
2 = 0.055,
medium-effect size) and left hippocampi (F1,104 = 6.19,
P = 0.014, ηp
2 = 0.056, medium-effect size) than CB-
nondep after controlling for these cannabis use measures.
Hippocampal volume comparisons by cannabis
dependence in matched subset—manual tracing
Finally, the subset of matched CON, CB-nondep and CB-
dep were compared on hippocampal volume. Gender dis-
tribution, age, IQ, alcohol use and tobacco use were
matched across groups within each site, apart from
Table 3 Sample characteristics and magnetic resonance volumetric measures of controls (CON), non-dependent (CB-nondep) and
dependent (CB-dep) cannabis users in matched subset, averaged across three sites [mean (SD)].
CON (N = 41) CB-nondep (N = 41) CB-dep (N = 41) F2,120/χ
2
Age (years) 26.09 (8.68) 28.58 (10.81) 26.71 (8.54) 0.79
Gender (% M/F) 63.4/36.6 63.4/36.6 63.4/36.6 0.00
IQa 107.35 (8.87) 103.33 (12.11) 103.92 (8.78) 1.92
Alcohol (StDr/mth)b 24.39 (27.15) 20.65 (22.84) 20.52 (17.22) 0.38
Tobacco (Cig/mth)b 76.28 (143.36) 238.83 (253.82) 213.64 (187.22) 7.84**c
Cannabis use
Age of regular use - 17.82 (2.81) 17.48 (2.58) 0.57
Current use (cones/month) - 235.40 (209.86) 278.94 (172.76) 1.03
Lifetime use (cones) - 38 340 (50 702) 37 288 (45 640) 0.10
Volumetric measures (mm3)
Intracranial volume (106) 1.54 (0.17) 1.49 (0.18) 1.50 (0.17) 0.40
Right hippocampus
Manual 2525.00 (311.25) 2466.44 (290.37) 2355.56 (310.13) 3.97*d
FreeSurfer 4487.90 (451.50) 4454.43 (341.31) 4366.09 (436.79) 1.22d
Left hippocampus
Manual 2373.05 (316.76) 2366.93 (313.91) 2246.15 (287.54) 3.15*d
FreeSurfer 4500.68 (458.74) 4413.65 (421.80) 4309.69 (462.13) 1.82d
aEstimated intelligence quotient (IQ) measured with the Dutch version of the National Adult Reading Test (Schmand et al. 1991) (Amsterdam), the
vocabulary subscale of the Wechsler Adult Intelligence Scale—Third Edition (Wechsler 1997) (Barcelona); and the Wechsler Abbreviated Scale of
Intelligence (Wechsler 1999) (Melbourne). bStDr/mth = standard drinks per month; Cig/mth = cigarettes smoked per month. cCON < CB-nondep,
P < 0.001; CON < CB-dep, P = 0.002. dF statistic for group comparison of hippocampal volume, controlling for imaging site as random factor, gender
as fixed factor and ICV, age, IQ and monthly alcohol and tobacco use as covariates. Refer to Supplementary Table S5 for full results. *P < 0.05.
**P < 0.01. ***P < 0.001.
Hyphen indicates that no data are available/necessary for those places – i.e. non-user controls do not have cannabis use data.
2 Four CON from the Amsterdam site used between 15 to 50
cannabis joints in their lifetime. When analysis was re-run ex-
cluding these subjects, the significant dependence effect
remained (F2,211 = 5.72 and 4.41, P = 0.004 and 0.013) for
the right and left hippocampus, respectively.
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Melbourne, for which we were unable to match tobacco
use. Furthermore, CB-nondep and CB-dep were matched
on all previously mentioned variables (i.e. gender, age,
IQ and alcohol and tobacco use) and cannabis use
pattern. The effect of cannabis dependence persisted for
the right (F1,112 = 3.97, P = 0.022, ηp
2 = 0.066) and left
hippocampi (F1,112 = 3.15, P = 0.047, ηp
2 = 0.053). CB-
dep users demonstrated significantly smaller hippocampi
than CB-nondep users in both hemispheres (P = 0.016
and P = 0.022, respectively) and a smaller right hippo-
campus than CON (P = 0.020).
Hippocampal shape comparisons by cannabis use and
dependence—manual tracing
Cluster-based shape analysis was performed controlling
for ICV, imaging site, gender, IQ, age, alcohol use and to-
bacco use. Comparison between (1) CON and CB revealed
no significant shape difference between groups. However,
comparison between (2) CON, CB-nondep and CB-dep
demonstrated a significant shape difference between CB-
nondep and CB-dep in the right and left hippocampus
(Fig. 2a, d) but not between CON and CB-nondep or
CON and CB-dep.3 Specifically, deflation occurred along
the superior-medial body of the hippocampi of CB-dep
relative to CB-nondep. Nevertheless, when comparison
was performed between the subset of (3) matched CON,
CB-nondep and CB-dep, deflation in CB-dep relative to
CB-nondep did not survive family-wise error (FWE)-cor-
rection across the image space.
Hippocampal volume and shape—FreeSurfer versus
manual tracing
All hippocampal volume and shape analyses were repli-
cated using the automated segmentation software
FreeSurfer. FreeSurfer performance was also validated,
relative to manual tracing, by examining the correlation
between both methods, and the percent volume overlap.
Results for FreeSurfer-segmented hippocampal compari-
son between (1) CON and CB, (2a) CON, CB-nondep
and CB-dep, (2b) CB-nondep and CB-dep only, and (3)
matched subset of CON, CB-nondep and CB-dep are pre-
sented in Supplementary Table S5. Briefly, there was no
significant hippocampal volume difference between CON
and CB, but CB-dep users similarly showed a smaller left
hippocampus than CB-nondep users (P = 0.013). When
only CB-nondep and CB-dep users were compared, addi-
tionally controlling for cannabis use pattern, CB-dep
users again demonstrated significantly smaller right and
left hippocampi relative to CB-nondep users (P = 0.027
and P = 0.005, respectively). When the matched subset
of CON, CB-nondep and CB-dep were compared, however,
no significant dependence effect was found. Cluster-based
shape analysis of FreeSurfer-segmented hippocampi
meanwhile only demonstrated a shape difference be-
tween CB-dep and CB-nondep users that did not survive
FWE-correction. While the FreeSurfer-segmented hippo-
campi were strongly correlated with the manual tracing
(R = 0.72 and 0.66 for the right and left hippocampus,
respectively, P < 0.001), the FreeSurfer hippocampi are
systematically larger than the manual output, as illus-
trated in the Bland–Altman plot (Supplementary Fig.
S3). Estimation of volume overlap between both methods
suggests an average volume overlap of 71.2 percent
(SD = 4.39 percent) and 70.10 percent (SD = 4.75 per-
cent) for the right and left hippocampus, respectively.
3 Four CON from the Amsterdam site used between 15 to 50
cannabis joints in their lifetime. When analysis was re-run ex-
cluding these subjects, results remained similar.
Figure 1 Right and left hippocampal volume in controls
(CON), non-dependent (CB-nondep) and dependent
(CB-dep) cannabis users, corrected for intracranial volume
and gender; bars represent 95% confidence interval;
*P < 0.05 **P < 0.01
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The larger hippocampal volume produced by FreeSurfer
may be due to its greater tendency to include surround-
ing structures and cerebrospinal fluid, as illustrated in
example slices in Supplementary Fig. S3.
DISCUSSION
In this large-scale multi-site study, we demonstrated sig-
nificant hippocampal volume reduction only in cannabis
dependent users relative to both non-user CON and
non-dependent users, irrespective of extent of cannabis
use. Shape difference was also observed in the right and
left hippocampus, only in dependent users (deflation of
the superior-medial body) relative to non-dependent
users. These results suggest that hippocampal volume
and shape alterations may be specific to cannabis depen-
dence rather than non-dependent regular cannabis use.
Our findings are consistent with previous work reflecting
dependence-specific effects, e.g. in neuroanatomical and
functional alteration across the cortical and limbic
regions (Filbey & Dunlop 2014; Chye et al. 2017a; Chye
et al. 2017b). Future investigative efforts should thus be
mindful in assessing and discriminating between canna-
bis use and dependence when evaluating the harms and
vulnerabilities associated with chronic cannabis use.
Hippocampal volumetric reduction is the most consis-
tently reported neuroanatomical finding in regular can-
nabis users relative to non-users (Rocchetti et al. 2013;
Koenders et al. 2016; Yücel et al. 2016; Lorenzetti et al.
2016c; Chye et al. 2017b) but was not observed in all
studies (e.g. Tzilos et al. 2005; Medina et al. 2007; Gilman
et al. 2014; Mashhoon et al. 2015; Weiland et al. 2015).
We were well-powered to detect group differences in a
large sample (aggregated across well-controlled studies
from four international research sites) and found no vol-
ume reduction in cannabis use per se but specifically in
dependent users. Notably, these findings were not driven
by cannabis use level (i.e. monthly or lifetime use), sug-
gesting cannabis dependence-specific effects on hippo-
campal morphology to be dissociated from those due to
level of cannabis use. This contrasts previous reports of
a dose-dependent association between hippocampal
volume and cannabis dosage (Yücel et al. 2008; Ashtari
et al. 2011; Cousijn et al. 2012). However, none of the
aforementioned studies discriminated between dependent
and non-dependent users in their samples and might not
have been able to dissociate hippocampal differences
linked to dosage versus dependence. Indeed, less than
40 percent of frequent cannabis users (i.e. using
≥3 days/week for ≥1 year) will develop a dependence
Figure 2 (a, b) Cross-sectional coronal, axial and sagittal slices of magnetic resonance scans and (c, d) 3D rendering of the right and left
hippocampus, depicting areas of deflation in hippocampal shape in CB-dep compared with CB-nondep users
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syndrome, irrespective of level of use (van der Pol et al.
2013c). This distinction in the cannabis user population
(i.e. dependence versus non-dependence) may explain
why a number of studies have failed to detect hippocam-
pal volume differences in cannabis users compared with
CON, as these studies may have included varying propor-
tions of dependent and non-dependent users (Tzilos et al.
2005; Medina et al. 2007; Gilman et al. 2014; Mashhoon
et al. 2015; Weiland et al. 2015).
We also found a localized shape difference between de-
pendent and non-dependent users along the superior-
medial body of the hippocampus, roughly coinciding with
the cornu ammonis and dentate gyrus (CA3 and
CA4/DG) regions (Finegersh et al. 2011). While this re-
sult did not survive FWE correction in the subset of users
matched on age, IQ and substance use, it is possible that
the smaller sample (i.e. from 226 in the original analysis
to 123 in this analysis) resulted in reduced power to de-
tect subtle shape effects. Hippocampal shape alterations
in cannabis users have only been examined in four prior
studies, demonstrating regional shape differences in cur-
rent users, recreational users (Mdn = 6–10 lifetime use)
and users with a past cannabis use disorder (Solowij
et al. 2013; Smith et al. 2015; Orr, Paschall, & Banich
2016; Koenders et al. 2017). Our finding is consistent
with previous reported alterations in regular cannabis
users [i.e. shape deflation along the hippocampal head
and body (Solowij et al. 2013; Koenders et al. 2017)]
and in dependent users [i.e., reduced CA3 and CA4/DG
volume (Chye et al. 2017b)]. Deflation confined to the
CA3 and CA4/DG hippocampal subregions is noteworthy
as these are the major sites for adult neurogenesis and
subsequent innervation of new neurons, a process crucial
for learning and memory, as well as affective and stress
regulation (Canales 2007; Chambers 2013). Indeed,
poorer cognitive and emotive functioning are docu-
mented in dependent cannabis users (Solowij & Battisti
2008; van der Pol et al. 2013a; Broyd et al. 2016). We
were unfortunately unable to explore whether cannabis
dependence-related hippocampal morphology mediates
differences in cognitive and emotive functioning (e.g. de-
pressive or anxiety symptoms) in the current study. Such
knowledge may be useful for understanding the interac-
tion between cannabis dependence and functioning in re-
lation to brain structure and presents a potential avenue
for future work.
Prominent theories of addiction propose that vulnera-
bilities in the decision-making process coupled with dis-
tress associated with negative mood states are the key
drivers in persistent substance taking observed in sub-
stance dependence (Koob 2008; Koob & Le Moal 2008;
Redish, Jensen, & Johnson 2008; Volkow & Morales
2015). Our finding of hippocampal alteration specific to
cannabis dependence supports theories suggesting
dependence-specific neuroalterations. The amygdala–
hippocampal system is involved in affective processing
(Ekhtiari, Victor, & Paulus 2017), with impaired hippo-
campal functioning (e.g. low hippocampal neurogenesis)
further linked to poor stress regulation (Hyman & Sinha
2009; Schloesser, Manji, & Martinowich 2009).
Increased stress reactivity and negative mood state pose
a vulnerability factor which is strongly associated with
dependence in cannabis users, beyond and distinct from
extent of cannabis use (Stewart 2003; Koob 2009; van
der Pol et al. 2013c). Additionally, hippocampal function
is also necessary to guide learning and adaptive behavior,
with impaired function suggested to restrict the complex-
ity and flexibility of motivational learning that subserves
the extinction of substance use behavior, thus contribut-
ing to the maintenance of dependence (Canales 2007;
Chambers, Bickel, & Potenza 2007; Redish et al. 2008;
Chambers 2013). While future efforts are necessary to
expand on the link between hippocampal neuroanatomy
and the cognitive, stress and affective regulation process
guiding cannabis dependence, it nonetheless appears that
dependent cannabis users may be distinctly impacted in
neuroanatomy (Filbey & Yezhuvath 2013; Chye et al.
2017a; Chye et al. 2017b).
Finally, we compared the consistency between two
separate methods of measuring hippocampal volumes,
i.e. FreeSurfer and manual segmentation (refer to
Supporting Information), and showed that these were
highly correlated (about 70 percent volume overlap).
FreeSurfer produced systematically larger hippocampi
than did manual segmentation, which may be due to
its greater tendency to include surrounding structures
and cerebrospinal fluid (refer to the example slices in
Supplementary Fig. S3). However, we still found a
significant effect of cannabis dependence in FreeSurfer-
segmented hippocampi (i.e. in analyses controlling for
cannabis use pattern but not in the matched subset
analyses, Supplementary Table S5), suggesting mostly
consistent results from both methods. The manual
segmentation method is considered the gold standard
for evaluating hippocampal volume (Velakoulis et al.
1999) and assumed to be superior to automated
methods (i.e. SPM, FSL and FreeSurfer), as it allows
for a more fine-grained inspection of hippocampal
volume and shape. Meanwhile, FreeSurfer’s estimations
of hippocampal volume tend to show a larger variance,
in addition to a tendency to underestimate gray matter
volume with increasing scanner noise, causing its out-
put to be more subject to hardware-related differences
(Butts 2013; Wenger et al. 2014; Fellhauer et al.
2015). As such, when assessing impacts on the
morphology of the hippocampus, it may be preferable
for studies to adopt manual tracing methods wherever
feasible.
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Some limitations of this study must be addressed. Col-
lating a mega-analysis from multiple imaging sites meant
that site-related factors such as scanner differences and
geographical differences could have confounded the
results. To address this, we controlled for imaging site in
all our group analyses. Furthermore, the hippocampal
volume of cannabis dependent users was clearly reduced
relative to non-dependent users and CON at every site,
suggesting that no single site was driving the observed
results (Supplementary Fig. S2). Secondly, the cross-
sectional nature of our analysis precludes interpretation
on the causality of the effects, i.e. whether altered hippo-
campal morphology pre-exists or is consequent to canna-
bis use and dependence. Finally, as different imaging sites
have adopted different instruments in measuring canna-
bis dependence, we could not directly compare levels of
dependence severity with hippocampal morphology
across sites or examine severity in regression models.
Instead, we adopted validated cut-offs (Lecrubier et al.
1997; Swift, Copeland, & Hall 1998; van der Pol, et al.
2013b) to consistently investigate hippocampal morphol-
ogy between dependent and non-dependent users. Stud-
ies using consistent diagnostic instruments of substance
use disorders (e.g. DSM-5; American Psychiatric Associa-
tion 2013) are needed to verify the association between
hippocampal morphology and dependence severity, par-
ticularly in further delineating the relationship between
dependence, cognitive and affective regulation and the
neuroanatomy of substance users (Solowij, Lorenzetti, &
Yücel 2016; Lorenzetti et al. 2016a; Lorenzetti et al.
2016b; Lorenzetti et al. 2016c).
CONCLUSION
We extend on previous studies of hippocampal morpho-
logical alteration (i.e. shape and volume) in non-
dependent and dependent cannabis users in a large
multi-site imaging cohort, using both manual tracing
and automated methods. Hippocampal volume reduction
was specific to dependent users, even after controlling for
cannabis dosage and sample characteristic (i.e. age, IQ
and alcohol and tobacco use). There was also an emerg-
ing shape difference along the superior-medial boundary
of the hippocampus, between dependent and non-
dependent users. Our findings suggest that not all canna-
bis users are alike, with a subgroup of vulnerable users—
dependent users—showing hippocampal morphological
alterations compared with non-dependent users and
CON. Further steps should be made to characterize and
verify the neural and behavioral differences that separate
non-dependent and dependent cannabis users in large
normative samples and treatment-seeking populations,
whether as vulnerability factors or consequent of use, to
better identify and pre-empt the transition of cannabis
users to dependence.
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SUPPORTING INFORMATION
Additional supporting information may be found online
in the Supporting Information section at the end of
the article.
Table S1. Assessment instruments by imaging site
Table S2. Sample characteristics and MR volumetric
measures of controls (CON) and cannabis users (CB) at
each site (mean (SD))
Table S3. Sample characteristics and MR volumetric
measures of controls (CON), non-dependent (CB-nondep)
and dependent (CB-dep) cannabis users at each site
where dependence measures were available (mean (SD))
Table S4. Sample characteristics and MR volumetric
measures in matched subset of controls (CON), non-de-
pendent (CB-nondep) and dependent (CB-dep) cannabis
users at each site where dependence measures were
available (mean (SD))
Table S5. Group comparison results of right and left hip-
pocampal volume, with both manual tracing method and
automated FreeSurfer method
Figure S1. Flow chart of hippocampal shape analysis
steps, using the Oxford Centre for Functional MRI of the
Brain (FMRIB) Software Library (FSL). (a, blue) trans-
form hippocampal object maps (ROI) to standard (MNI)
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space; (b, orange) average all hippocampal objects (ROI)
to form an average boundary (ROIBound); (c, green) sep-
arately binarise each hippocampal object (ROIBin); (d,
purple) calculate signed distance (Dis) between
binarised hippocampal object maps and average bound-
ary; (e, red) run group comparison on distance maps.
T1 = T1-weighted MRI, subscript number indicates sub-
jects’ ID, DOF = degree of freedom
Figure S2. Average hippocampal volume (collapsed
across hemisphere) in controls (CON), non-dependent
(CB-nondep) and dependent (CB-dep) cannabis users,
separated by imaging site, and corrected for intracranial
volume (ICV) and gender; bars represent 95% confidence
interval. * p<.05; ** p<.01, *** p<.001
Figure S3. (A) Cross-sectional coronal, axial and sagittal
slices of an example MR scan with overlay of FreeSurfer
and manual hippocampus, and (B,C) Bland-Altman
mean-difference plots for right and left hippocampal
volumes.
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